The National Cancer Institute’s Cancer Imaging Program (CIP) is recruiting for a Medical Officer (Clinical) (GP-0602-15) position with a focus in medical imaging, for the Diagnostic Imaging Branch (DIB) of the CIP. The CIP is responsible for the planning, evaluation, and coordination of extramural NCI research related to oncology imaging. Major efforts include multi-center clinical trials, imaging informatics, such as imaging genomic correlations (http://cancerimagingarchive.net), reducing regulatory hurdles to novel imaging agent testing, and participation in the National Clinical Trials Network (NCTN). The DIB has the primary responsibility to provide oversight, strategic input and monitoring for advanced clinical imaging activities in NCI and supports a portfolio of clinical trials that use or evaluate imaging in an integral or integrated manner. These multi-center trials that are managed by CIP or the Cancer Therapy Evaluation Program require the oversight and leadership of a senior medical officer to provide guidance and timely scientific feedback.
The preferred candidate will have experience in clinical trials with familiarity in diagnostic use and/or development of imaging methods, regulatory requirements for clinical imaging biomarker development (validation and performance) and in the science of prognostic and predictive biomarkers medical imaging (oncology), and the NIH grant process, and regulations for imaging drugs and devices. An active US medical license, board certification in a relevant specialty (radiology or nuclear medicine) and five years’ experience post-training (residency and fellowship) are required. Additionally, the medical officer must have expertise in current research and practice in imaging biomarkers and predictive markers as well as trends in clinical trial methodology. This position requires strategic development of clinical trials with extramural investigators, which correspond to CIP’s trials, particularly: 1) enhancing response to therapy by employing the most appropriate imaging evaluations; 2) developing and validating new imaging methods and technologies; and 3) initiating and evaluating precision clinical studies to elucidate and employ the molecular underpinnings of tumor response and resistance.
The medical officer will provide authoritative clinical expertise in advising the Chief of the Diagnostic Imaging Branch, the Associate Director of the CIP, and senior NCI leadership on the establishment, development, and implementation of policies and procedures covering the design of novel imaging clinical trials. Will serve as an expert clinical advisor in the development of policies and systems for implementing this new approach to testing new drug development. In addition, he/she would be expected to provide expert clinical advice to scientists and physicians involved in the administration of the clinical trials, both therapeutic and imaging primary studies. The medical officer will also spend 10% of their time in active clinical work at the NIH Clinical Center.
The medical officer will be eligible for a salary commensurate with his/her qualifications and experience. Full Federal Benefits will be provided. For full details and qualification questions please contact Dr. Lalitha K Shankar, MD, PhD, Chief of the DIB, (firstname.lastname@example.org) or 240-276-5936. For additional details and application procedures, go to the vacancy announcement for Medical Officer (Clinical) at https://www.usajobs.gov/GetJob/ViewDetails/475463200NIH-NCI-DH-17- 1989090. Opening 7/31/2017 and Closing 8/9/2017.
DHHS, NIH, and NCI are Equal Opportunity Employers
About National Cancer Institute/National Institute of Health
The NCI Cancer Imaging Program fosters advances in in vivo medical imaging sciences through support of basic and applied research in cancer imaging as well as promotion of imaging in clinical trials in order to gain greater understanding of the pathways of cancer biology for the benefit of cancer patients and people at cancer risk